ESC Premium Access

Comparison of efficacy of different anticoagulation strategies used during pulmonary vein isolation in left atrial blood samples

Congress Session

About the speaker

Doctor Orsolya Hajas

University of Debrecen, Debrecen (Hungary)
0 follower

9 more presentations in this session

Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries

Speaker: Doctor G. Montrasio (Zurich, CH)

Thumbnail

Heparin and low-molecular-weight heparin switch associated with an increase in bleeding complications in patients on apixaban undergoing catheter ablation: The AMPER ABLATION study

Speaker: Doctor W. Amara (Le Raincy-Montfermeil, FR)

Thumbnail

Amiodarone treatment duration and reasons for permanent drug discontinuation in patients with atrial fibrillation

Speaker: Doctor M. Mihajlovic (Belgrade, RS)

Thumbnail

Use of direct thrombin inhibitor on the day of atrial fibrillation ablation decreases incidence of silent cerebral ischemia detected by magnetic resonance imaging

Speaker: Associate Professor M. Harada (Toyoake, JP)

Thumbnail

Efficacy and safety of dronedarone after recent cardioversion in patients with atrial fibrillation/flutter: a post-hoc analysis of the EURIDIS/ADONIS trials

Speaker: Professor H. Crijns (Maastricht, NL)

Thumbnail

Access the full session

Poster Session 2 - Drug treatment for atrial fibrillation

Speakers: Doctor O. Hajas, Doctor G. Montrasio, Doctor W. Amara, Doctor M. Mihajlovic, Associate Professor M. Harada...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk